Skip to main content
. 2022 Feb 23;9(1):e000625. doi: 10.1136/lupus-2021-000625

Figure 2.

Figure 2

(A) Time-adjusted average SLEDAI scores in patients with initial IFN high and IFN low results, and in patients with stable IFN high and IFN low results. (B) Percentage time spent in Lupus Low Disease Activity State (LLDAS) in patients with initial IFN high and IFN low results, and in patients with stable IFN high and IFN low results. (C) Relationship between SLEDAI and IFN-stimulated genes (ISGs) in patients with ≥3 samples and a change in SLEDAI of ≥3 across the study period. IFN, interferon; SLEDAI, SLE Disease Activity Index.